ATE270889T1 - Monoaminoxidase inhibitor- und h5-ht 1 beta antagonist oder partiellagonist enthaltende mischung - Google Patents
Monoaminoxidase inhibitor- und h5-ht 1 beta antagonist oder partiellagonist enthaltende mischungInfo
- Publication number
- ATE270889T1 ATE270889T1 AT98944376T AT98944376T ATE270889T1 AT E270889 T1 ATE270889 T1 AT E270889T1 AT 98944376 T AT98944376 T AT 98944376T AT 98944376 T AT98944376 T AT 98944376T AT E270889 T1 ATE270889 T1 AT E270889T1
- Authority
- AT
- Austria
- Prior art keywords
- monoamin
- mixture containing
- partial agonist
- oxidase inhibitor
- beta antagonist
- Prior art date
Links
- 239000002876 beta blocker Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 title 1
- 239000004031 partial agonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9703376A SE9703376D0 (sv) | 1997-09-18 | 1997-09-18 | A new combination |
| PCT/SE1998/001602 WO1999013878A1 (en) | 1997-09-18 | 1998-09-09 | A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE270889T1 true ATE270889T1 (de) | 2004-07-15 |
Family
ID=20408296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98944376T ATE270889T1 (de) | 1997-09-18 | 1998-09-09 | Monoaminoxidase inhibitor- und h5-ht 1 beta antagonist oder partiellagonist enthaltende mischung |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6159970A (de) |
| EP (1) | EP1014986B1 (de) |
| JP (1) | JP2001516719A (de) |
| KR (2) | KR20010024084A (de) |
| CN (1) | CN1278727A (de) |
| AR (1) | AR013503A1 (de) |
| AT (1) | ATE270889T1 (de) |
| AU (1) | AU752719B2 (de) |
| BR (1) | BR9812236A (de) |
| CA (1) | CA2302204A1 (de) |
| DE (1) | DE69825062T2 (de) |
| DK (1) | DK1014986T3 (de) |
| EE (1) | EE200000146A (de) |
| ES (1) | ES2222603T3 (de) |
| HU (1) | HUP0100621A2 (de) |
| ID (1) | ID25789A (de) |
| IL (1) | IL134775A0 (de) |
| IS (1) | IS5401A (de) |
| MX (1) | MXPA00002616A (de) |
| NO (1) | NO20001400L (de) |
| PL (1) | PL339368A1 (de) |
| PT (1) | PT1014986E (de) |
| SE (1) | SE9703376D0 (de) |
| SK (1) | SK2832000A3 (de) |
| TR (1) | TR200000725T2 (de) |
| WO (1) | WO1999013878A1 (de) |
| ZA (1) | ZA987804B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4957948A (en) * | 1988-05-05 | 1990-09-18 | Interface, Inc. | Biocidal protective coating for heat exchanger coils |
| SE9601110D0 (sv) | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| WO2002066454A1 (en) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Chromene derivatives |
| JP5080716B2 (ja) * | 2001-07-20 | 2012-11-21 | サイコジェニックス・インコーポレーテッド | 注意欠陥・多動性障害の治療 |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| US20090054453A1 (en) * | 2006-03-17 | 2009-02-26 | Lilian Alcaraz | Novel Tetralins as 5-HT6 Modulators |
| WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| SI2091948T1 (sl) | 2006-11-30 | 2012-07-31 | Probiodrug Ag | Novi inhibitorji glutaminil ciklaze |
| EP2481408A3 (de) | 2007-03-01 | 2013-01-09 | Probiodrug AG | Neue Verwendung von Inhibitoren der Glutaminyl Cyclase |
| DK2142514T3 (da) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thioureaderivater som glutaminylcyclase-inhibitorer |
| AU2010294214B2 (en) | 2009-09-11 | 2015-05-07 | Vivoryon Therapeutics N.V. | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
| EP2560953B1 (de) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Hemmer der glutaminylzyklase |
| JP6050264B2 (ja) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
| CN110179988A (zh) * | 2019-07-10 | 2019-08-30 | 王大伟 | 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9119932D0 (en) * | 1991-09-18 | 1991-10-30 | Glaxo Group Ltd | Chemical compounds |
| ATE204262T1 (de) * | 1991-09-18 | 2001-09-15 | Glaxo Group Ltd | Benzanilidderivate als 5-ht1d-antagonisten |
| SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
-
1997
- 1997-09-18 SE SE9703376A patent/SE9703376D0/xx unknown
-
1998
- 1998-08-27 ZA ZA987804A patent/ZA987804B/xx unknown
- 1998-09-09 DK DK98944376T patent/DK1014986T3/da active
- 1998-09-09 MX MXPA00002616A patent/MXPA00002616A/es unknown
- 1998-09-09 PL PL98339368A patent/PL339368A1/xx unknown
- 1998-09-09 ID IDW20000522D patent/ID25789A/id unknown
- 1998-09-09 DE DE69825062T patent/DE69825062T2/de not_active Expired - Fee Related
- 1998-09-09 AU AU91931/98A patent/AU752719B2/en not_active Ceased
- 1998-09-09 ES ES98944376T patent/ES2222603T3/es not_active Expired - Lifetime
- 1998-09-09 JP JP2000511500A patent/JP2001516719A/ja active Pending
- 1998-09-09 TR TR2000/00725T patent/TR200000725T2/xx unknown
- 1998-09-09 WO PCT/SE1998/001602 patent/WO1999013878A1/en active IP Right Grant
- 1998-09-09 HU HU0100621A patent/HUP0100621A2/hu unknown
- 1998-09-09 EE EEP200000146A patent/EE200000146A/xx unknown
- 1998-09-09 BR BR9812236-3A patent/BR9812236A/pt not_active IP Right Cessation
- 1998-09-09 CN CN98811114A patent/CN1278727A/zh active Pending
- 1998-09-09 PT PT98944376T patent/PT1014986E/pt unknown
- 1998-09-09 SK SK283-2000A patent/SK2832000A3/sk unknown
- 1998-09-09 KR KR1020007002830A patent/KR20010024084A/ko not_active Application Discontinuation
- 1998-09-09 US US09/171,578 patent/US6159970A/en not_active Expired - Fee Related
- 1998-09-09 KR KR1020007002835A patent/KR20010024087A/ko active Search and Examination
- 1998-09-09 IL IL13477598A patent/IL134775A0/xx unknown
- 1998-09-09 CA CA002302204A patent/CA2302204A1/en not_active Abandoned
- 1998-09-09 AT AT98944376T patent/ATE270889T1/de not_active IP Right Cessation
- 1998-09-09 EP EP98944376A patent/EP1014986B1/de not_active Expired - Lifetime
- 1998-09-17 AR ARP980104635A patent/AR013503A1/es unknown
-
2000
- 2000-03-14 IS IS5401A patent/IS5401A/is unknown
- 2000-03-17 NO NO20001400A patent/NO20001400L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE9703376D0 (sv) | 1997-09-18 |
| DK1014986T3 (da) | 2004-10-25 |
| WO1999013878A1 (en) | 1999-03-25 |
| EE200000146A (et) | 2001-02-15 |
| KR20010024084A (ko) | 2001-03-26 |
| DE69825062D1 (de) | 2004-08-19 |
| AU752719B2 (en) | 2002-09-26 |
| CA2302204A1 (en) | 1999-03-25 |
| TR200000725T2 (tr) | 2000-08-21 |
| IL134775A0 (en) | 2001-04-30 |
| NO20001400D0 (no) | 2000-03-17 |
| US6159970A (en) | 2000-12-12 |
| SK2832000A3 (en) | 2000-09-12 |
| MXPA00002616A (es) | 2002-04-24 |
| EP1014986B1 (de) | 2004-07-14 |
| AR013503A1 (es) | 2000-12-27 |
| PL339368A1 (en) | 2000-12-18 |
| AU9193198A (en) | 1999-04-05 |
| KR20010024087A (ko) | 2001-03-26 |
| ES2222603T3 (es) | 2005-02-01 |
| CN1278727A (zh) | 2001-01-03 |
| PT1014986E (pt) | 2004-10-29 |
| BR9812236A (pt) | 2000-07-18 |
| IS5401A (is) | 2000-03-14 |
| JP2001516719A (ja) | 2001-10-02 |
| EP1014986A1 (de) | 2000-07-05 |
| HUP0100621A2 (hu) | 2001-08-28 |
| NO20001400L (no) | 2000-05-05 |
| DE69825062T2 (de) | 2005-08-25 |
| ID25789A (id) | 2000-11-02 |
| ZA987804B (en) | 1999-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE270889T1 (de) | Monoaminoxidase inhibitor- und h5-ht 1 beta antagonist oder partiellagonist enthaltende mischung | |
| AT503376A3 (de) | Synergistische spot-on-formulierung | |
| FI961720A0 (fi) | Uusi koostumus | |
| HUP0101809A2 (hu) | 5-és 3-as típusú 17béta-hidroxi-szteroid dehidrogenáz inhibitorok és ezeket tartalmazó gyógyászati készítmények | |
| PL339371A1 (en) | Composition containing 5-ht reuptake inhibitor and antagonist or partial agonist of h5-ht 1b | |
| HUP9801227A3 (en) | Pharmaceutical compositions comprising monoamine oxidase b inhibitors and their use | |
| DE69620642T2 (de) | Reiningungsverfahren und-zusammensetzung | |
| EP1069901A4 (de) | Kalcilytische verbindungen und verwendungsmethode | |
| HUP0003039A3 (en) | Synergistic fungicidal mixture and use thereof | |
| HUP9901320A3 (en) | Synergistic herbicidal composition and method of use thereof | |
| EG21286A (en) | Blends of organosillane compounds and their use | |
| PT826679E (pt) | Compostos de naftilo intermediarios composicoes e metodos de utilizacao | |
| BR9711684A (pt) | Composi-Æo para gaxeta e gaxeta | |
| PL339370A1 (en) | Composition containing selective antagonist of 5-ht 1a and selective antagonist or partial agonist of h5-ht 1b | |
| ID17419A (id) | Komposisi dekafluoropentana | |
| BR9510407A (pt) | Composição fotopolimerizável com acetilenos e processos para a fotopolimerização de acetilenos | |
| NO972216D0 (no) | Acrotein-frigjörende sammensetning og dens anvendelse | |
| BR9700132A (pt) | Composição contendo aditivos e coadjuvantes para a preservação de bebidas | |
| BR7300054U (pt) | Kit para higiene pessoal e de material de escitório | |
| BR9503359A (pt) | Mistura nao-azeotrópica | |
| BR9611976A (pt) | Uso de agentes de ensilagem e composição de ensilagem | |
| BR7301386U (pt) | Kit multiprocessador de legumes e similares | |
| PT101501A (pt) | Almofada de dureza e peerfil regulavel | |
| GB9707163D0 (en) | Cleaning composition and method of use | |
| SE9603301D0 (sv) | Compounds and compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1014986 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |